Thubilux Pharma SpA has received a structured loan of US$2.7 million from a leading Italian bank
Tubilux Pharma SpA has successfully raised funds through a structured loan from Cassa Depositi e Prestiti SpA and Banca Intesa San Paolo SpA to support an investment plan for a new production facility which has all the FDA requirements to enter the USA market.
Tubilux Pharma is a leading, privately-held ophthalmic and pharmaceuticals company that develops and markets a range of proprietary, over-the-counter, and branded generic products, with distribution in approximately 30 countries. The firm's customers are large multinational pharmaceutical companies that outsource their production of ophthalmic products to specialized manufactures through medium-term supply contracts (3-5 years).
Oaklins' team in Italy advised Thubilux Pharma SpA in the structuring, negotiation and closing of a long-term debt financing from a leading Italian bank, backed by Cassa Depositi e Prestiti.
Talk to the deal team
Marie Gabriella Sestini
Bigtincan (ASX:BTH) has successfully raised funds via an institutional placement
Bigtincan Holdings (ASX:BTH) has successfully completed an institutional placement. The raising was completed alongside the recently announced acquisition of ClearSlide, a sales engagement technology platform leader with over 500 customers across three continents. Funds will also be used to support the acquisition integration, working capital and future growth of the company.Learn more
Mizrahi Tefahot has issued bonds worth US$125 million
Mizrahi Tefahot Issuing Company Ltd. has completed a fundraising to refinance and develop the company.Learn more
Groupe Voie Lactée has been acquired by Initiative & Finance
JFC Industrie has sold Groupe Voie Lactée to Initiative & Finance.Learn more